Omega Protein Corp. Company Profile (NYSE:OME)

Analyst Ratings

Consensus Ratings for Omega Protein Corp. (NYSE:OME) (?)
Ratings Breakdown: 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $22.00 (1.52% upside)

Analysts' Ratings History for Omega Protein Corp. (NYSE:OME)
Show:
DateFirmActionRatingPrice TargetActions
4/28/2016WunderlichInitiated CoverageBuy$22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/20/2016Pivotal ResearchUpgradeHold -> Buy$19.00 -> $23.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/14/2015DA DavidsonDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/20/2015BB&T Corp.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015Imperial CapitalUpgradeIn-Line -> Outperform$16.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Omega Protein Corp. (NYSE:OME)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/4/2016Q116$0.36$0.40$84.74 million$84.84 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/9/2016Q415$0.48$0.29$101.83 million$82.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.35$0.66$100.59 million$112.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.24$0.43$84.99 million$93.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q115$0.15$0.12$74.30 million$71.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/11/2015Q414$0.17$0.35$83.30 million$102.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/17/2014Q314$0.30$0.08$70.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2014$0.25$0.42ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2014Q312$0.32$0.66$69.47 million$66.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$0.14$0.19$50.93 million$41.77 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Omega Protein Corp. (NYSE:OME)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.26$0.40$0.33
Q2 20162$0.45$0.54$0.50
Q3 20163$0.39$0.53$0.44
Q4 20162$0.14$0.41$0.28
Q1 20171$0.38$0.38$0.38
Q2 20171$0.42$0.42$0.42
Q3 20171$0.57$0.57$0.57
Q4 20171$0.43$0.43$0.43
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Omega Protein Corp. (NYSE:OME)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Omega Protein Corp. (NYSE:OME)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/4/2015Andrew JohannesenCFOSell5,298$23.26$123,231.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Mark Edward GriffininsiderSell29,561$21.83$645,316.63View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Mark Edward GriffininsiderSell20,439$21.60$441,482.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Andrew JohannesenCFOSell1,000$14.00$14,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Gregory P ToupsVPSell1,115$13.95$15,554.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015David Andrew OwenDirectorSell8,929$13.77$122,952.33View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Gregory P ToupsVPSell2,000$13.46$26,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Gregory P ToupsVPSell4,000$13.10$52,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2014Gregory P ToupsVPSell2,500$14.75$36,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2014Gregory P ToupsVPSell2,500$15.25$38,125.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014Andrew JohannesenCFOSell3,000$15.02$45,060.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014John D HeldVPSell64,825$15.09$978,209.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Mark Edward GriffinInsiderSell2,300$14.77$33,971.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Andrew JohannesenCFOSell2,700$13.96$37,692.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Gregory P ToupsVPSell2,500$14.75$36,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2014Mark Edward GriffinInsiderSell9,492$14.74$139,912.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2014Montgomery DeihlInsiderSell4,000$14.59$58,360.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2014Gregory P ToupsVPSell5,000$14.33$71,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2014Gregory ToupsVPSell5,000$13.37$66,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2014William LandsDirectorSell10,000$11.85$118,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013William E M LandsDirectorSell10,000$10.61$106,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2013David Andrew OwenDirectorBuy1,333$10.31$13,743.23View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/1/2013David Andrew OwenDirectorBuy1,888$6.06$11,441.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2012David Andrew OwenDirectorBuy1,305$6.80$8,874.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Omega Protein Corp. (NYSE:OME)
DateHeadline
07/22/16 05:29 PMHow Analysts Rated Omega Protein Corporation (NYSE:OME) Last Week? - Consumer Eagle
07/21/16 03:15 PMOmega Protein Announces Second Quarter 2016 Earnings Conference Call - [PR Newswire] - HOUSTON, July 21, 2016 /PRNewswire/ -- Omega Protein Corporation (NYSE:OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, will announce ...
07/21/16 08:30 AMA Fish-Stinking History
07/21/16 08:30 AMWorld Dietary Supplements Market worth 179.8 Billion USD by 2020
07/14/16 09:14 AMGlobal Fish Oil Market to Progress at 4.8% CAGR from 2014 to 2020
07/07/16 08:32 AMFish Oil Market to get an Excellent Boost due to its Numerous Benefits
07/06/16 10:14 AMNorthampton fish kill cause uncertain
07/03/16 05:01 PMOmega Protein Corporation (NYSE:OME) Target Price Is $21.666 - RealistInvestor.com
07/03/16 09:51 AMRecently Issued Stock Ratings For Omega Protein Corporation (NYSE:OME) - Fiscal Standard
07/02/16 08:26 AMThousands of headless, tailless fish wash up on Eastern Shore beaches
07/01/16 04:22 PMOmega Protein Corp. – Value Analysis (NYSE:OME) : July 1, 2016 -
07/01/16 03:37 PMOMEGA PROTEIN CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of -
07/01/16 08:26 AMEating Fish Can Be A Little Fishy - Grit Magazine
06/30/16 07:15 AMOmega Protein Corp. breached its 50 day moving average in a Bullish Manner : OME-US : June 30, 2016 -
06/29/16 08:29 AMOmega Protein shareholders elect activist investor's board nominees - Daily Mail
06/28/16 05:36 PMOmega Protein shareholders elect activist's board nominees
06/28/16 12:55 PMOmega Protein shareholders elect activist investor's board nominees -
06/28/16 10:56 AMWynnefield Capital's Full Slate Of Independent Nominees Resoundingly Elected To Board Of Omega Protein Corporation - [PR Newswire] - NEW YORK, June 28, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" ...
06/28/16 10:28 AMHigh-Quality Whey Protein (in the Right Amounts) May Be Helpful for Weight Loss - ProHealth
06/27/16 08:10 AM5 Reasons Why You Should Invest in J.M. Smucker (SJM) Now -
06/24/16 05:34 PMGym-free fitness ideas anyone can do - Wausau Daily Herald
06/24/16 08:12 AMOmega Protein Corporation (NYSE:OME) Updated Price Targets - FTSE News
06/23/16 06:09 PMInflamed and stressed: Antioxidant solutions that repair and rejuvinate - NutraIngredients.com
06/23/16 08:19 AMHow blood biomarker analysis can help plan meals, boost performance - Sports Illustrated
06/21/16 05:10 PMDeclines in fish supply threaten developing countries, UAPB professor says - Pine Bluff Commercial
06/21/16 10:02 AMPea Milk Is Now a Thing That Exists - InStyle
06/20/16 05:28 PMReady-to-Use Next-Gen Tahini Launches at Fancy Food - PR Newswire (press release)
06/20/16 05:28 PMAre you tired and forgetful all the time? How to banish the brain fog - Mirror.co.uk
06/20/16 05:28 PM13 Nutrients To Consume For A Happier Outlook On Life, According To Experts - Bustle
06/20/16 07:15 AMTwo firms recommend voting against Omega board director - IntraFish.com
06/18/16 04:54 PMAquaculture feed industry needs 'profitable' Chile salmon sector, Biomar says - Undercurrent News
06/18/16 09:49 AMBRIEF-Omega Protein responds to reports from ISS and Glass Lewis relating to directors election - Reuters
06/17/16 05:26 PMOmega Protein Clarifies Critical Facts for Stockholders
06/17/16 08:24 AMElla Allred recommends how to eat right for your AGE - Daily Mail
06/17/16 08:24 AMFalling Fish Catches Could Mean Malnutrition in Developing World - Laboratory Equipment
06/17/16 08:24 AMProxy Advisor Glass Lewis Recommends That Omega Protein Stockholders Vote For Wynnefield Nominee Michael ... - PR Newswire (press release)
06/17/16 07:51 AMProxy Advisor Glass Lewis Recommends That Omega Protein Stockholders Vote For Wynnefield Nominee Michael Christodolou To Replace Incumbent Director Gary Ermers - [PR Newswire] - NEW YORK, June 17, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (OME) ("Omega" or the "Company") with a 7.9% ownership interest, today announced that Glass, Lewis & Co. ("Glass Lewis"), a leading independent proxy voting and corporate governance advisory firm, recommended that its clients vote FOR the election of Wynnefield independent nominees Michael N. Christodolou and David H. Clarke to Omega's Board of Directors, thereby replacing director Gary Ermers. Glass Lewis joins Institutional Shareholder Services in recommending their clients vote for Wynnefield's independent nominees.
06/16/16 06:51 AMISS backs activist directors for Omega Protein's board - [Reuters] - A shareholder advisory service has recommended that Omega Protein Corp. stock holders vote for two directors brought forward by an activist investor to serve on the company's board. Institutional Shareholder Services (ISS) threw its support behind Michael Christodolou and David Clarke, two board candidates that Wynnefield Capital has nominated in its proxy fight against the nutritional product company. ISS found Wynnefield's nominees are more likely to deliver changes needed at the company than the targeted incumbent board members, the New York hedge fund said in a press release.
06/16/16 06:00 AMInstitutional Shareholder Services Recommends That Omega Protein Stockholders Vote For Wynnefield Nominee Michael Christodolou To Replace Incumbent Director Gary Ermers - [PR Newswire] - NEW YORK, June 16, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" ...
06/14/16 04:18 PMNevada State Court Orders Omega Protein To Produce NOBO Shareholder List By 3PM PT On Thursday, June 16, 2016 - [PR Newswire] - NEW YORK, June 14, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega or the ...
06/14/16 02:59 PMOmega Protein Announces Court Denies Wynnefield's Motion For Preliminary Injunction - [at noodls] - HOUSTON, June 14, 2016 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today issued ...
06/14/16 02:56 PMOMEGA PROTEIN CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits -
06/14/16 08:30 AMThe Zacks Analyst Blog Highlights: Dean Foods, Omega Protein, Tyson Foods and United Natural Foods -
06/13/16 08:35 AMWynnefield Capital : Issues Letter To Omega Protein Stockholders
06/13/16 07:45 AMWynnefield Capital Issues Letter To Omega Protein Stockholders - [PR Newswire] - "Michael Christodolou is an excellent potential director of OME – we've known Mike for 25 years and would concur that he would be terrific for OME," investment research report released on March 10, 2016 by Pivotal Research Group, a strong supporter of Omega Protein.
06/13/16 07:19 AMOmega Protein Details Important Facts For Stockholders - [at noodls] - HOUSTON, June 13, 2016 /PRNewswire/ -- The Board of Directors of Omega Protein Corporation (NYSE: OME) (the 'Company' or 'Omega Protein'), today released a letter to stockholders in connection with the ...
06/09/16 04:27 PMWynnefield Capital Comments On Recent Omega Protein Communications, Is Disappointed Over Release Of Private Communications - Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" or the "Company") with a 7.9% beneficial ownership interest, today commented on a package of recent communications released by Omega, including its investor presentation, dated June 7, 2016, and a letter sent to stockholders, dated June 8, 2016. Wynnefield believes that Omega's communications destroy their credibility and are clearly designed to mislead stockholders and divert them from the damaging facts about their Board's poor decisions, lack of qualifications and repeated governance failures. Nelson Obus, President of Wynnefield, said "In the last few days, Omega has released a series of communications that together reflect the Board's and management's misguided attempt to further entrench themselves by preventing the election of Michael Christodolou to Omega's Board, despite his superior qualifications compared to current director Gary Ermers. We are puzzled as to why Omega's Board is afraid of Mr. Christodolou's independent perspective, judgement and vast expertise. "Likewise, we are disappointed that the Board has resorted to releasing private communications from an impassioned stockholder, who is not even a nominee for the board. Omega should be focused on making the case for why Gary Ermers is better suited than Michael Christodolou. Omega's Board and its external advisors are more concerned with jumping in muddy puddles than correcting the strategic, operational and governance deficiencies that they have presided over. "The facts, however, speak for themselves…in the four calendar years (ending December 31, 2015), Omega's Board and management team have allocated approximately $168 million of capital towards a Human Nutrition segment, included therein is a $23.6 million loss from operations – diverting valuable resources and management's time from a high margin Animal Nutrition business that generated $235.4 million of operating income over the same time period. "The current Board not only presided over this strategic and operational failure but has taken numerous shareholder unfriendly actions to entrench themselves. This should come as no surprise to the investment community. This is the same Board that has historically been unresponsive to stockholders' concerns and has routinely put their interests before stockholders. This is also the same Board that has done everything it can to prevent Michael Christodolou from joining its ranks, beginning with refusing to meet or to even speak with a highly qualified nominee like Michael in the Fall of 2015, particularly when he had been simply suggested by one of the Company's largest and longest term stockholders to fill a vacancy that still remains to this day. "It is resoundingly clear to Wynnefield, and other concerned stockholders, that Omega's behavior is a last-ditch effort to obfuscate the fact that Mr. Ermers is not qualified to serve on Omega's Board and that Mr. Christodolou is a vastly superior nominee who would serve the best interests of the Company and protect stockholder value by installing a disciplined strategic and capital allocation mentality. While Wynnefield looks forward to directly engaging with stockholders, it believes it is prudent to point out at least some of the major distortions embedded in the Company's presentation. 1. Nominee Qualifications. On slide 28, Omega states that Michael Christodolou lacks any "relevant, additive skills" including Operational Risk Management Duties, Direct Finance and Audit Experience, M&A/Business Development. This is laughable, given the fact that Michael Christodolou: Has a combined 22 years of serving with distinction on several public company boards, including for 17 years as a director and 12 years as Chairman of Lindsay Corporation, an agricultural related company, as well as 21 years of aggregate service on public company audit committees. Intimately involved in the strategic planning, analysis, approval and board oversight of approximately one dozen acquisitions valued at approximately $200 million during his tenure with Lindsay. Has 30+ years of accomplishments as a professional investor collaborating with and assisting the management teams and boards of directors of public companies on corporate and financial strategies to enhance shareholder value, including acquisitions, divestitures, operational restructurings and optimized capital structures. On the other hand, Board incumbent Gary Ermers is a hospital executive with no relevant expertise, though he does have a prior personal relationship with Omega Board member David Owen, Chair of the Company's Governance Committee. Ermers and Owen are long-time friends and neighbors, having served simultaneously on the Barkley Wood Homeowners' Association in Nicholasville, Kentucky. Prior to being appointed to Omega's Board by Mr. Owen and others in 2014, Mr. Ermers had never served on a public company board. He will for the first time face Omega stockholders at this year's Annual Meeting. A comparison of the candidates qualifications speak for themselves and can be found in an Exhibit below. 2. Human Nutrition performance and facts are absent. On slide 10, Omega compares its Animal Nutrition and Human Nutrition revenue to consolidated gross profit and margin. However, it conveniently does not disclose how much of the gross profit/margin comes from each of the businesses because they don't want stockholders to know how little comes from Human Nutrition given the size of the business and how much money Omega squandered to develop it. There is no disputing that Human Nutrition gross margins (approximately 12%) are not as attractive as Animal Nutrition gross margins (nearly 37%). Omega makes no effort to justify spending $168 million on a business that has lost $23.6 million over the last four calendar years (ending December 31, 2015) nor does it provide an explanation as to why the Human Nutrition segment is worth a fraction of the $168 million committed – based on statements made by the Company's CEO on the last earnings call. 3. Cherry Picking Peer Group to Fabricate Performance. On slides 14-19, when discussing total shareholder return (TSR), Omega has once again skewed perspective and changed its peer group materially, altering ...Full story available on Benzinga.com
06/09/16 03:38 PM4:38 pm Omega Protein: Wynnefield Capital (7.9% stake) comment on a package of recent communications released by Omega -
06/09/16 03:35 PMWynnefield Capital Comments On Recent Omega Protein Communications - [PR Newswire] - NEW YORK, June 9, 2016 /PRNewswire/ -- Wynnefield Capital and its affiliates (collectively, "Wynnefield"), longstanding stockholders of Omega Protein Corporation (NYSE: OME) ("Omega" ...
06/09/16 07:29 AMOmega Protein to Present at the Oppenheimer 16th Annual Consumer Conference - [at noodls] - HOUSTON, June 9, 2016 /PRNewswire/ -- Omega Protein Corporation (NYSE: OME), a nutritional product company and a leading integrated provider of specialty oils and specialty protein products, today announced ...

Social

About Omega Protein Corp.

Omega Protein Corp. logoOmega Protein Corporation is a nutritional products company that develops, produces and delivers nutritious products across the world. The Company operates through two segments: animal nutrition and human nutrition. The Company's animal nutrition segment consists primarily of two subsidiaries: Omega Protein, Inc. (Omega Protein) and Omega Shipyard, Inc. (Omega Shipyard). Omega Protein operates approximately three menhaden processing plants in the states of Louisiana, Mississippi and Virginia. The human nutrition segment does business under the name Bioriginal, which includes all of the human nutrition businesses. Bioriginal has over three primary product lines: plant and marine based specialty oils, protein products and other nutraceutical ingredients. Bioriginal consists of approximately four subsidiaries: Bioriginal Food & Science Corp. (Bioriginal Food & Science), Wisconsin Specialty Protein, L.L.C. (WSP), Cyvex Nutrition, Inc. (Cyvex) and InCon Processing, L.L.C. (InCon).

Industry, Sector and Symbol:
  • Sector: Consumer Staples
  • Industry: Processed & Packaged Goods
  • Sub-Industry: Packaged Foods & Meats
  • Exchange: NYSE
  • Symbol: OME
  • CUSIP: 68210P10
Key Metrics:
  • Previous Close: $21.67
  • 50 Day Moving Average: $20.03
  • 200 Day Moving Average: $19.69
  • P/E Ratio: 15.97
  • P/E Growth: 1.59
  • Market Cap: $482.20M
  • Beta: 0.88
  • Current Year EPS Consensus Estimate: $1.71 EPS
  • Next Year EPS Consensus Estimate: $1.82 EPS
Additional Links:
Omega Protein Corp. (NYSE:OME) Chart for Monday, July, 25, 2016